| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |